Skip to main content
Have a personal or library account? Click to login
Pulmonary Thromboembolism Following Radio-Frequency Ablation of the Atrioventricular Node in a Patient Heterozygous for the Factor V Leiden and the Mthfr C677T Mutations Cover

Pulmonary Thromboembolism Following Radio-Frequency Ablation of the Atrioventricular Node in a Patient Heterozygous for the Factor V Leiden and the Mthfr C677T Mutations

Balkan Journal of Medical Genetics
Volume 14 (2011): Issue 1 (June 2011)
By: ,  ,  ,  ,   and    
Open Access
|Jul 2011
References

References

  1. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008; 358(10): 1037-1052.
    Open DOISearch in Google Scholar
  2. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematol Am Soc Hematol Educ Program. 2005:1-12.
    Open DOISearch in Google Scholar
  3. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor(activated protein C resistance). Blood 1995; 85(6): 1504-1508.
    Open DOISearch in Google Scholar
  4. Zöller B, García de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologica. 1999; 84(1):59-70.
    Search in Google Scholar
  5. Djordjevic V, Rakicevic L, Gagic M, Nikolic A, Savic A. Simultaneous detection of factor V Leiden and factor II G20210A variants by a multiplex PCR on whole blood. Balkan J Med Genet. 2001; 4(1&2): 15-17.
    Search in Google Scholar
  6. Djordjevic V, Stankovic M, Nikolic A, Antonijevic N, Rakicevic LJ, Divac A, Radojkovic M. PCR amplification on whole blood samples treated with different commonly used anticoagulants. Pediatr Hematol Oncol. 2006; 23(6): 517-521.
    Open DOISearch in Google Scholar
  7. Koebe J, Kirchhof P. Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation. Europace. 2008; 10(4): 433-437.
    Open DOISearch in Google Scholar
  8. Papagiannis J, Papadopoulou K, Rammos S, Demosthenes Katritsis D. Cryoablation versus radiofrequency ablation for atrioventricular nodal reentrant tachycardia in children: long-term results. Hellenic J Cardiol. 2010; 51(2): 122-126.
    Search in Google Scholar
  9. Lin JL, Stephen Huang SK, Lai LP, Ko WC, Tseng YZ, Lien WP. Clinical and electrophysiologic characteristics and long-term efficacy of slow-pathway catheter ablation in patients with spontaneous supraventricular tachycardia and dual atrioventricular node pathways without inducible tachycardia. J Am Coll Cardiol. 1998; 31(4): 855-860.
    Open DOISearch in Google Scholar
  10. O'Hara GE, Philippon F, Champagne J, Blier L, Molin F, Côté JM, Nault I, Sarrazin JF, Gilbert M. Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital. Can J Cardiol. 2007; 23(Suppl B): 67B-70B. (Erratum: Can J Cardiol. 2009; 25(3): 140.)
    Open DOISearch in Google Scholar
  11. Mansourati J, Deharo JC, Graux P, Chappuis L, Durieu C, Dutoit A, Guillo P, Djiane P, Blanc JJ. Short and medium-term outcome after radiofrequency ablation of the atrioventricular junction. Arch Mal Coeur Vaiss. 1997; 90(7): 945-951. [Article in French]
    Search in Google Scholar
  12. Darpö B, Walfridsson H, Aunes M, Bergfeldt L, Edvardsson N, Linde C, Lurje L, van der Linden M, Rosenqvist M. Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation.1997; 80(9): 1174-1177.
    Open DOISearch in Google Scholar
  13. Haman L, Parízek P, Alý R, Duda J, Malý J. Analysis of thrombotic complications after catheter ablation. Acta Medica (Hradec Kralove). 2006; 49(1): 47-50.
    Open DOISearch in Google Scholar
  14. Aznar J, Vaya A, Estelles A, Mira Y, Segui R, Villa P, Ferrando F, Falco C, Corella D, Espana F. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica. 2000; 85(12): 1271-1276.
    Search in Google Scholar
  15. Coen D, Zadro R, Honovic L, Banfic L, Stavljenic Rukavina A. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Croat Med J. 2001; 42(4): 488-492.
    Search in Google Scholar
  16. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to a poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993; 342(8886-8887): 1503-1506.
    Open DOISearch in Google Scholar
  17. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999; 19(3): 511-518.
    Open DOISearch in Google Scholar
  18. Mandala M, Curigliano G, Bucciarelli P, Ferretti G, Mannucci PM, Colleoni M, Ventura A, Peruzzotti G, Severi G, Pelicci PG, Biffi R, Orsi F, Cinieri S, Goldhirsch A. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol. 2004; 15(4): 590-593.
    Open DOISearch in Google Scholar
  19. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis. 2005; 19(3): 189-196.
    Open DOISearch in Google Scholar
  20. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost. 1997; 78(6): 1426-1429.
    Open DOISearch in Google Scholar
  21. Howard TE, Marusa M, Boisza J, Young A, Sequeira J, Channell C, Guy C, Benson E, Duncan A. The prothrombin gene 3'-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency. Blood. 1998; 91(3):1092-1093.
    Open DOISearch in Google Scholar
  22. Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti ML, Bignell M, Mannucci PM. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep vein thrombosis in patients with mutant factor V (factor V:Q). Arterioscler Thromb Vasc Biol. 1997; 17(9): 1662-1666.
    Open DOISearch in Google Scholar
  23. Nagorni-Obradovic Lj, Miljic P, Djordjevic V, Pesut D, Jovanovic D, Stojsic J, Stevic R, Radojkovic D. The prothrombin factor II G20210A mutation with pulmonary thromboembolism and a normal level of fibrin degradating products. Balkan J Med Genet. 2009; 12(2): 69-76.
    Open DOISearch in Google Scholar
  24. Yamamoto T, Ito M, Nagata S, Suzuki H, Tagawa A, Nagase M, Hishida AJ. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. J Rheumatol. 2000; 27(8): 2035-2037.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10034-011-0018-z | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 51 - 55
Published on: Jul 25, 2011
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Thromboembolism,
Radiofrequency ablation,
Atrioventricular (AV) node,
Factor V (FV) Leiden mutation,
Risk factor
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2011 D Pešut, S Raljević, M Kontić, D Božić, I Buha, R Stević, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 14 (2011): Issue 1 (June 2011)
Previous article
Next article